Amarin Makes Moves towards Global Expansion of Vazkepa
Pharmaceutical Technology
SEPTEMBER 22, 2022
The pharmaceutical company is well on its way to achieving its goals with successful full reimbursements, already confirmed in the United Kingdom ( UK), and Sweden. This was a landmark event as Vazkepa was the first FDA-approved drug for use in combination with statin therapies for hypertriglyceridemic patients.
Let's personalize your content